0
Second Opinion |

COPD Stand FREE TO VIEW

Rob Rogers
Chest. 2014;146(2):249. doi:10.1378/chest.146.2.249
Text Size: A A A
Published online

The prevalence of Chronic Obstructive Pulmonary Disorder (COPD) has increased globally, creating a significant market for companies dealing in products for treating lung disease.


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543